Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Indonesia Energy Corporation Limited (INDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Indonesia Energy Corporation Limited — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while Indonesia Energy Corporation Limited trades at $2.66 (market cap $41.08M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 752.9× Indonesia Energy Corporation Limited's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Indonesia Energy Corporation Limited pays none. Which is the better fit depends on your goals.
| GEHC | INDO | |
|---|---|---|
Market Cap | $30.93B | $41.08M |
Volume | 5,033,451 | 144,476 |
Sector | Health | Energy |
52-Week High | $88.16 | $6.74 |
52-Week Low | $59.48 | $2.49 |
Enterprise Value | $39.39B | $36.02M |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
INDO trades at $2.75 with minimal daily movement (+0.36%). The stock shows bearish technical signals despite unanimous analyst buy ratings. Fundamentally, the company faces significant challenges with negative profit margins (-152.72% net income margin) and consistent quarterly losses, though recent oil discoveries at the K-29 well provide operational optimism. Cash flow remains dependent on financing activities to offset negative operational cash flow.
While analyst consensus remains bullish with 100% buy ratings, the stock presents high-risk exposure due to persistent unprofitability and negative cash generation. The company's exploration success offers potential upside, but investors face substantial execution risk and financial instability in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →
